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demonstrated that siRNA for Ank reduced 4-fold more than
siRNA for PC-1 the inducing effect of TGF-β1 on ePPi levels.
We showed that neither SB203580 (a p38 MAPK inhibitor), nor
RcAMP (a PKA inhibitor) were able to modulate Ank induc-
tion, but that PD98059 (a MEK 1 inhibitor) was strongly active,
ensuring a 50% inhibition of TGF-β-1-induced Ank expression.
On the other hand, the effect of PKC inhibitors depended on
their selectivity: PKCδ inhibitor (rottlerin) was weakly effective
compared to Ca2+-dependent PKC inhibitor (Gö6976), that di-
minished Ank expression by 60%, suggesting the involvement
of calcium-dependent PKC in the regulation of Ank gene by
TGF-β1. Finally, we demonstrated with plasmids transfection the
involvement of Ras, Raf-1 and conﬁrmed the contribution of ERK
in Ank mRNA regulation. However, overexpression of Smad 7
did not affect Ank expression, showing that Smad-dependent
signaling events downstream to TGF-β1 were not implicated.
Conclusions: These results indicate that TGF-β1 mediates an
increase in ePPi concentration, mainly by induction of Ank ex-
pression, which depends on activation of Ras, Raf-1, ERK and
Ca2+-dependent PKC pathways in chondrocyte. Our results un-
derline the interest to modulate Ras/Raf-1/ERK or PKC signaling
pathways in chondrocytes, as it could open insights for the treat-
ment of sporadic chondrocalcinosis.
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Purpose: It has been reported that the early stage of osteoarthri-
tis (OA) is characterized by hypertrophic differentiation and apop-
tosis of chondrocytes, which mimics the developmental process
of growth plate chondrocytes. The level of inorganic phosphate
(Pi) elevates at the site of cartilage mineralization, and previous
studies have proposed that Pi entry into hypertrophic chondro-
cytes may act as an apoptogen. The Bcl-2 family proteins, which
consist of pro- and anti-apoptotic members, are major regulators
of mitochondria-initiated apoptosis. In this study, we investigated
how they determine the cell fate of chondrocytes.
Methods: We developed an in vitro system to analyze the mech-
anism of hypertrophic differentiation and apoptosis of chondro-
cytes using chondrogenic ATDC5 cells. Using this culture system,
the expression levels of pro- and anti-apoptotic Bcl-2 members
were analyzed by real time RT-PCR or western blotting, and
their roles in chondrocyte apoptosis by gene overexpression
and gene silencing. Association between anti-apoptotic member
Bcl-xL and pro-apoptotic member Bnip3 was examined by im-
munoprecipitation, and their expression patterns in growth plate
chondrocytes were investigated by immunohistological staining.
Finally, we generated chondrocyte-speciﬁc knockout mice of anti-
apoptotic Bcl-2 family member protein Bcl-xL using the Cre-loxP
recombination system, and examined its roles in vivo.
Results: When differentiated ATDC5 cells were treated with Pi,
they mineralized the surrounding matrix and underwent rapid
apoptosis as evidenced by nuclear condensation, Caspase-3
& 7 activation, and Lamin proteolysis. In this culture system,
among 15 pro-apoptotic Bcl-2 family members, 7 molecules in-
creased their expression levels during the course of hypertrophic
differentiation, and two in response to Pi stimulation. Of these,
gene silencing of a proapoptotic BH3-only molecule bnip3 by
RNA interference signiﬁcantly suppressed Pi-induced apoptosis.
Conversely, among anti-apoptotic members examined, overex-
pression of bcl-xL suppressed, and its knockdown promoted
apoptosis. The susceptibility to apoptosis by bcl-xL knockdown
was partially restored by simultaneous silencing of bnip3. Pi
treatment markedly upregulated the protein levels of Bnip3 with-
out affecting Bcl-xL levels. Bnip3 was associated with Bcl-xL and
attenuated its anti-apoptotic effect in chondrocytes. Immunohisto-
logical examination of murine growth plates revealed that Bcl-xL
expressed uniformly in the growth plate chondrocytes, whereas
Bnip3 expression was exclusively localized in the hypertrophic
chondrocytes. Finally, we generated chondrocyte-speciﬁc bcl-xL
knockout mice using the Cre-loxP recombination system, and
provided evidence that the hypertrophic chondrocyte layer was
markedly shortened in those mice owing to massive chondro-
cyte apoptosis and that the mice exhibited dwarﬁsm as a result.
Furthermore, Bnip3 expression was decreased in hypertrophic
chondrocytes in mice fed with a low phosphate diet, and the
abnormalities in the growth plate were almost completely res-
cued.
Conclusions: Increase in Pi levels in hypertrophic zone causes
upregulation of Bnip3 in chondrocytes, which binds to Bcl-xL
and consequently impairs its anti-apoptotic effect, and ﬁnally
causes apoptosis of the cells. Our observations will open a
new therapeutic approach for OA by modulating the function
of Bcl-xL/Bnip3 axis and consequently regulating chondrocyte
apoptosis.
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Purpose: Interleukin 6 (IL-6) production is elevated in affected
joints of osteoarthritis (OA) patients. The central role played by
IL-6 in joint inﬂammation and destruction has suggested thera-
pies targeting IL-6 for treatments of arthritic diseases. However,
increased severity of spontaneous cartilage damage in IL6-/-
mice suggests a protective role by IL-6 in joint homeostasis. The
aim of this study was to examine the effects of blocking IL-6 sig-
naling on both catabolic and anabolic gene regulation in human
primary chondrocytes (HACs) by small interfering RNA (siRNA)
technology and antibody treatment.
Methods: Small interfering RNA-mediated gene-speciﬁc knock-
down of IL-6 signaling components (IL-6 or IL-6R) was applied
to achieve blockade of IL-6 signaling in human primary chondro-
cytes (HACs) treated with catabolic (IL-1β) or anabolic (TGF-β
or IGF-1+OP-1) stimuli. To conﬁrm the siRNA effects in chon-
drocytes, a neutralizing anti-IL-6 antibody was also studied for
effects in response to IL-1β treatment. Expression of the mRNA
for chondrocytic genes was determined by quantitative real-time
PCR (Taqman). The protein level of IL-6 and MMP-13 were
measured using immunochemical based assays.
Results: Transfection of IL-6 and IL-6R siRNA into chondrocytes
resulted in signiﬁcant gene speciﬁc knockdown of IL-6 and IL-
6R mRNA, respectively. In addition, knockdown of IL-6 led to
a drastic reduction in IL-1β-induced expression of IL-6 mRNA
and protein. Decreased IL-6 expression also led to a marked re-
duction in IL-1β-induced expression of pro-inﬂammatory cytokine
TNF-α, and cartilage degrading enzymes such as MMP-13 and
ADAMTS-4. The inhibitory effects by IL-6 siRNA were speciﬁc to
IL-6 signaling, as similar effects were exhibited by both IL-6 neu-
tralizing antibody and IL-6R siRNA. Surprisingly, IL-6 appears to
modulate gene expression in chondroctyes under anabolic stim-
ulation. We found that the expression of several essential ECM
and cartilage components, in particular collagen II (Col2a), was
not induced by TGF-β or IGF-1/OP-1 in cells transfected with
IL-6 siRNA.
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Conclusions: Inhibition of IL-6 in IL-1β stimulated chondrocytes
resulted in reduced mRNA expression of pro-inﬂammatory cy-
tokines and cartilage-degrading enzymes. This indicates the
involvement of IL-6 in catabolic regulation in chondrocytes.
However, blocking IL-6 seemed to also affect the anabolic re-
sponses in chondroctyes. Decreased expression of key cartilage
molecules in response to anabolic treatments suggests a protec-
tive role for IL-6 in the chondrocyte. Our data provide evidence
suggesting that the cytokine, IL-6, could also have beneﬁcial
effects and could contribute to promoting cartilage repair pro-
cesses. Therefore, it will be crucial to monitor patients receiving
IL-6 blocking treatment closely for their joint health.
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Purpose: Obesity increases the risk of developing osteoarthri-
tis (OA) in both load-bearing and non-load-bearing joints. This
suggests that a systemic factor is involved, which is potentially
mediated by body fat itself. Obesity elevates circulating free fatty
acid (FA) levels, and OA is associated with increased intra-
articular FA content. Furthermore, adipose tissue is an active
endocrine organ that secretes numerous signaling molecules
(i.e., adipokines). One adipokine in particular, leptin, is associ-
ated with OA and acts synergistically with interleukin-1 (IL-1)
to increase inﬂammation in chondrocytes. We hypothesized that
leptin would function synergistically with IL-1 to increase gly-
cosaminoglycan (GAG) breakdown and nitric oxide production in
articular cartilage explants. We also investigated how elevated
fatty acids inﬂuence these effects.
Methods: Articular cartilage explants were harvested from the
femoral condyles of skeletally mature pigs. Explants were al-
lowed to stabilize in culture medium with 10% FBS for 72 h at
37 degrees C. Media were then replaced with either 0, 1, 10, or
100 ng/ml recombinant human leptin (BACHEM) with or without
the following treatments, for 48 hrs: a) 0.5 mM FA (1:1 oleic
and palmitic acids; SIGMA), b) 0.1 ng/ml recombinant porcine
IL-1alpha (R&D Systems), or c) a combination of 0.5 mM FA +
0.1 ng/ml IL-1alpha. Total sulfated (S)-GAG release into the me-
dia was measured using the 1,9-dimethylmethylene blue (DMB)
assay. To assess nitric oxide production, we measured the con-
centration of total nitrate and nitrite (termed “NOx”) in the media
using the Griess reaction assay. Results were divided by the wet
weight of the explant and normalized to the average control con-
dition value per joint (i.e., 0 ng/ml leptin and no treatment). Each
dose and treatment condition represents the average of 3-4 joints
and 4-5 explants per joint. Statistical signiﬁcance for treatment
effects at 0 ng/ml leptin were determined with student’s t-test.
Signiﬁcant leptin dose effects were determined using a single
factor ANOVA, with Dunnett’s post-hoc test.
Results: Leptin had no independent effect on S-GAG release
or NOx production in articular cartilage explants (p>0.05). FA
treatment increased S-GAG release by 70%, which was negated
by 10 and 100 ng/ml of leptin (Fig. 1A). IL-1 increased S-GAG
release by 3.8-fold, which was further increased to approximately
7-fold with leptin doses of 1, 10, or 100 ng/ml (Fig. 1A). When FA
and IL-1 treatments were combined, S-GAG release increased
markedly by 13.4-fold above the control value (Fig. 1A). FA
treatment had no effect on NOx production, although when
combined with IL-1, it decreased NOx production compared to
IL-1 alone (58-fold vs 80-fold, respectively) (Fig. 1B). Leptin did
not signiﬁcantly affect IL-1 or IL-1 + FA induced NOx production
(Fig. 1B).
Figure 1. Open symbols are control values. *p<0.05 versus control. #p<0.05
versus smaller leptin dose. Values = mean ± SEM.
Conclusions: Palmitic and oleic FA, when combined with IL-1,
have a signiﬁcant synergistic effect on S-GAG release, more
than doubling the independent combined effects of FA and IL-1.
Leptin also acted synergistically with IL-1 to increase S-GAG
release, consistent with previously reported pro-inﬂammatory
effects of leptin on chondrocyte activity, although our results
were independent of nitric oxide production. Surprisingly, though,
leptin reduced FA-induced S-GAG release, suggesting that leptin
is protective against the catabolic effects of a high-FA load.
Leptin may attenuate FA-induced catabolism by stimulating FA
oxidation and reducing intra-cellular FA levels.
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Purpose: OA cartilage explants spontaneously produce PGE2,
the predominant eicosanoid of cyclooxygenase pathway, which
signals via four G-protein-coupled receptors, EP1-EP4. The
present study investigates the role of PGE2 on aggrecan
metabolism in chondrocytes.
Methods: OA chondrocytes were isolated from patients under-
going knee replacement surgery. Proteoglycan synthesis was de-
termined using 35S incorporation. MMP-13, cytokines were es-
timated using ELISA kits (R&D systems). Induction of ADAMTS
was determined using TaqMan real time PCR and fold change
was calculated and normalized with GAPDH using 2 delta Ct
method.
Results: The expression of prostaglandin biosynthetic pathway
